MarketInOut Stock Screener Log In | Sign Up

Procter & Gamble Health Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Procter & Gamble Health Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization83,541 mln
Float7.94 mln
Earnings Date11/02/2026

EPS

215
Exceptional

P / E

25.98
Elevated

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-0.61
Highly suspicious

Relative Strength

93 / 100
Top performer

Debt / Equity

0.02
Debt-free

Business Description

Procter & Gamble Health Limited is an India-based company that produces and sells a range of health products, including vitamins, minerals, and supplements, both within the country and abroad. Operating under well-known brands such as Neurobion, Evion, Livogen, and Seven Seas, the company serves everyday health needs across a broad customer base. Founded in 1967 and based in Mumbai, it runs as part of the global Procter & Gamble group.

Key Fundamentals

EPS215
P/E25.98
ROE58.33
RPS768
ROIC72.13
ROA38.76
Interest Cover787
EBITDA, mln4,740
EV / EBITDA19.65
EV / EBIT20.68
Revenue, mln14,080
EV / Revenue6.61

Quote Details

Last 5,590.00
Change 572.85 (11.42%)
Open 5,090.25
Volume 1,270
Turnover 7,099,300
Average Volume 602.81

Financial Ratios

Pre-Tax Profit Margin32
Current Ratio2.18
Price / Book17.60
Price / Tangible Book17.61
Price / Cash Flow48.19
Price / Free Cash Flow192
Debt / Equity0.02
Price / Sales6.56
PEG Ratio1.92

Financial Strength

Altman Z-Score22.09
Piotroski F-Score 5 / 9
Beneish M-Score-0.61
Price to Intrinsic Value9.26
Price to Lynch Fair Value2.81
Price to Graham Number4.70
Shiller PE Ratio29.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.46% 97 / 100   
1 Month 3.14% 86 / 100   
2 Months -17.8% 25 / 100   
6 Months 9.94% 73 / 100   
1 Year -7.24% 64 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog